Thomas J. Tisch, Director at SYNAGEVA BIOPHARMA CORP (GEVA), bought 36,500 shares at $41.20 ($1.5M) on 2012-07-12, disclosed to the SEC on 2012-07-13.
Open-market purchase of $1.5M GEVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GEVA | BUY | 2012-01-17 | $3.0M | — | Filing → |
| GEVA | BUY | 2012-01-11 | $30.2M | — | Filing → |